HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Sulfadiazine (Sulphadiazine)

Subscribe to New Research on Sulfadiazine

One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.

Also Known As:

Sulphadiazine; Sulfazin; Sulfazine; Zinc Sulfadiazine; Sulfadiazine, Zinc; Benzenesulfonamide, 4-amino-N-2-pyrimidinyl-

Networked: 674 relevant articles (58 outcomes, 70 trials/studies) for this Drug, Comments

Relationship Network

Drug Context: Research Results

Organic Chemicals: 41

Experts

1.	Schmidt, Dorte Remmer: 3 articles (01/2006 - 06/2003)
2.	Petersen, Eskild: 3 articles (01/2006 - 06/2003)
3.	Ferro, Eloisa A V: 2 articles (08/2009 - 07/2009)
4.	Liesenfeld, Oliver: 2 articles (11/2007 - 12/2004)
5.	Toxoplasmosis Study Group: 2 articles (05/2006 - 03/2006)
6.	Remington, Jack: 2 articles (05/2006 - 05/2002)
7.	McLeod, Rima: 2 articles (05/2006 - 03/2006)
8.	Latkany, Paul: 2 articles (05/2006 - 03/2006)
9.	Jalbrzikowski, Jessica: 2 articles (05/2006 - 03/2006)
10.	Boyer, Kenneth: 2 articles (05/2006 - 03/2006)

Related Diseases

1.	Toxoplasmosis 04/01/2009 - "Sulfadiazine-related stones are uncommonly reported, but they could be increasingly encountered owing to the use of sulfadiazine for human immunodeficiency virus-related toxoplasmosis. " 02/01/2004 - "These data provide a pharmacokinetic rationale for BID dosing of sulfadiazine for the treatment and suppression of toxoplasmosis." 09/01/2003 - "Although most cases are due to extrinsic compression, renal tract obstruction can also be due to intraluminal precipitation of sulfadiazine prescribed for maternofoetal toxoplasmosis. " 07/01/2000 - "Sulfadiazine acute nephrotoxicity is reviving specially because of its use in toxoplasmosis in HIV-positive patients. " 05/01/1949 - "Experimental toxoplasmosis; effect of sulfadiazine and antiserum on congenital toxoplasmosis in mice." Order ALL the reference details at left...
2.	Infection 04/01/2005 - "Finally, sulfadiazine was highly effective in protecting mice from infection with the tachyzoite stage of B. " 03/01/1948 - "Chemotherapeutic studies of 4-amino-4'-propylaminodiphenylsulfone alone and in combination with sulfadiazine in experimental pneumococcus infection." 07/01/2009 - "annua infusion before infection in HFF cells showed a dose-response inhibitory curve that reached up to 75% of inhibition, similarly to the results observed when parasites were treated with sulfadiazine. " 11/01/2007 - "In conclusion, the timing of sulfadiazine therapy is of utmost importance for the course of infection in immunocompromised mice." 11/01/2007 - "We observed that timing of sulfadiazine therapy had a marked impact on the course of infection and reactivation. " Order ALL the reference details at left...
3.	Burns 06/01/1992 - "CONCLUSIONS--All patients were treated as for burns using sulfadiazine and furacine. " 11/01/2007 - "CONCLUSION: In this study, the treatment of grade IIa burn wounds with hydrosome wound gel led to faster wound closure compared with treatment with sulfadiazine cream. " 08/01/2008 - "OBJECTIVES: The study was undertaken to evaluate the burn wound healing property of oil of Cocos nucifera and to compare the effect of the combination of oil of Cocos nucifera and silver sulphadiazine with silver sulphadiazine alone. " 02/01/1988 - "This study compares a moisture-vapour-permeable film (MVPF) with silver sulphadiazine in a randomized prospective manner for the treatment of outpatient burns. " 12/01/2006 - "Silver sulphadiazine cream in burns." Order ALL the reference details at left...
4.	Acquired Immunodeficiency Syndrome (AIDS) 07/01/1996 - "Correspondingly, the cumulative sulfadiazine dose at manifestation doubled in AIDS patients with a median of 84 g versus 40 g in controls. " 07/01/1996 - "Likely due to a high prevalence of potential risk factors, incidence of sulfadiazine-associated renal impairment was 1.9%-7.5% in AIDS patients and 1%-4% in HIV-negative controls. " 07/01/1996 - "Sulfadiazine-associated nephrotoxicity in patients with the acquired immunodeficiency syndrome." 10/31/1994 - "Sulfadiazine/N4-acetylsulfadiazine crystalluria in a patient with the acquired immune deficiency syndrome (AIDS)" 07/01/1994 - "Renal alterations induced by sulfadiazine therapy in an AIDS patients." Order ALL the reference details at left...
5.	Encephalitis (Encephalitis, Rasmussen) 04/01/1990 - "Most mice (6 of 10) treated for 3 days with 1 mg/ml sulfadiazine in drinking water developed encephalitis after drug treatment was stopped. " 08/01/2005 - "[Renal failure caused by sulfadiazine in a HIV patient with toxoplasmic encephalitis]" 11/01/2000 - "[Kidney failure caused by sulphadiazine in patients with toxoplasma encephalitis]" 11/19/1994 - "In the last few years high dose sulfadiazine therapy has been widely used for treatment of toxoplasmic encephalitis in AIDS patients. " 05/01/1991 - "We present here four patients with AIDS treated for toxoplasmic encephalitis who developed sulfadiazine-induced crystalluria. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Pyrimethamine (Daraprim)
2.	Trimethoprim (Proloprim)
3.	Clindamycin (Cleocin)
4.	Silver
5.	Silver Sulfadiazine (SSD)
6.	Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)
7.	Atovaquone (Mepron)
8.	Azithromycin (Zithromax)
9.	cerium nitrate
10.	co-trimazine

Related Therapies and Procedures

1.	Oral Administration
2.	Occlusive Dressings (Occlusive Dressing)
3.	Transplants (Transplant)
4.	Transurethral Resection of Prostate (TURP)
5.	Salvage Therapy

blog comments powered by Disqus

TREATMENT OPTIONS
for Toxoplasmosis,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 116 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Evidence References
Sample PDF Report on Psoriasis >>

Price:

$8.50 USD & Delivery via PDF download
updates for 1 year

Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:

Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
Enable Experts: Quickly identify key researchers and their publications
Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
Research Network: Explore drug and disease relationships visually
Enable Mobile Interface: Access from your cellphone, iPhone or PDA

Price:

$45.00 USD access via web interface
1 year subscription

Request Bulk Institution License Details >>